These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19341705)

  • 21. Comment on "Tumor growth need not be driven by rare cancer stem cells".
    Kennedy JA; Barabé F; Poeppl AG; Wang JC; Dick JE
    Science; 2007 Dec; 318(5857):1722; author reply 1722. PubMed ID: 18079385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of side population cells in human malignant mesothelioma cell lines.
    Kai K; D'Costa S; Yoon BI; Brody AR; Sills RC; Kim Y
    Lung Cancer; 2010 Nov; 70(2):146-51. PubMed ID: 20493579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor initiating potential of side population cells in human gastric cancer.
    Fukuda K; Saikawa Y; Ohashi M; Kumagai K; Kitajima M; Okano H; Matsuzaki Y; Kitagawa Y
    Int J Oncol; 2009 May; 34(5):1201-7. PubMed ID: 19360333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of murine and human acute myeloid leukemia stem cells.
    Deshpande AJ; Ahmed F; Buske C
    Methods Mol Biol; 2009; 568():21-35. PubMed ID: 19582419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of cells with neurogenic potential from adult skeletal muscle.
    Vourc'h P; Romero-Ramos M; Chivatakarn O; Young HE; Lucas PA; El-Kalay M; Chesselet MF
    Biochem Biophys Res Commun; 2004 May; 317(3):893-901. PubMed ID: 15081424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines.
    Skowron MA; Niegisch G; Fritz G; Arent T; van Roermund JG; Romano A; Albers P; Schulz WA; Hoffmann MJ
    J Exp Clin Cancer Res; 2015 Nov; 34():144. PubMed ID: 26606927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of chicken thrombopoietin and its receptor c-Mpl on hematopoietic cell development.
    Bartunek P; Karafiat V; Bartunkova J; Pajer P; Dvorakova M; Kralova J; Zenke M; Dvorak M
    Exp Hematol; 2008 Apr; 36(4):495-505. PubMed ID: 18243490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence cancer stem cells--made by cell fusion?
    Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
    Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilineage acute leukemia of T-lymphoid and myeloid lineages.
    Kobayashi N; Matsuda K; Sakashita K; Matsuzaki S; Iwasaki R; Koike K
    Haematologica; 2004 Sep; 89(9):1139-41. PubMed ID: 15377477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preliminary research of hepatocarcinoma stem cell markers].
    Yan Z; Fang CH; Gao P
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1304-6. PubMed ID: 16982441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cells in cancer: instigators and propagators?
    Alison MR; Islam S; Wright NA
    J Cell Sci; 2010 Jul; 123(Pt 14):2357-68. PubMed ID: 20592182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokines in neuroectodermal development and their potential implication in cancer stem cell-driven metastasis.
    Civenni G; Sommer L
    Semin Cancer Biol; 2009 Apr; 19(2):68-75. PubMed ID: 19084599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decontamination of leukemic cells and enrichment of germ cells from testicular samples from rats with Roser's T-cell leukemia by flow cytometric sorting.
    Hou M; Andersson M; Zheng C; Sundblad A; Söder O; Jahnukainen K
    Reproduction; 2007 Dec; 134(6):767-79. PubMed ID: 18042634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor growth need not be driven by rare cancer stem cells.
    Kelly PN; Dakic A; Adams JM; Nutt SL; Strasser A
    Science; 2007 Jul; 317(5836):337. PubMed ID: 17641192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is tumor growth sustained by rare cancer stem cells or dominant clones?
    Adams JM; Strasser A
    Cancer Res; 2008 Jun; 68(11):4018-21. PubMed ID: 18519656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Die hard: are cancer stem cells the Bruce Willises of tumor biology?
    Fábián A; Barok M; Vereb G; Szöllosi J
    Cytometry A; 2009 Jan; 75(1):67-74. PubMed ID: 19051297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD90 is identified as a marker for cancer stem cells in high-grade gliomas using tissue microarrays.
    Parry PV; Engh JA
    Neurosurgery; 2012 Apr; 70(4):N23-4. PubMed ID: 22426060
    [No Abstract]   [Full Text] [Related]  

  • 39. CD90 a potential cancer stem cell marker and a therapeutic target.
    Shaikh MV; Kala M; Nivsarkar M
    Cancer Biomark; 2016; 16(3):301-7. PubMed ID: 27062695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia/lymphoma.
    Kayo H; Yamazaki H; Nishida H; Dang NH; Morimoto C
    Biochem Biophys Res Commun; 2007 Dec; 364(4):808-14. PubMed ID: 17977513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.